These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


299 related items for PubMed ID: 16246056

  • 1. Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy.
    Paleologou KE, Irvine GB, El-Agnaf OM.
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1106-10. PubMed ID: 16246056
    [Abstract] [Full Text] [Related]

  • 2. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C, Lee SJ.
    J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G, Schlüter OM, Südhof TC.
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [Abstract] [Full Text] [Related]

  • 5. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
    El-Agnaf OM, Paleologou KE, Greer B, Abogrein AM, King JE, Salem SA, Fullwood NJ, Benson FE, Hewitt R, Ford KJ, Martin FL, Harriott P, Cookson MR, Allsop D.
    FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
    [Abstract] [Full Text] [Related]

  • 6. alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.
    Esposito A, Dohm CP, Kermer P, Bähr M, Wouters FS.
    Neurobiol Dis; 2007 Jun; 26(3):521-31. PubMed ID: 17408955
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of alpha-synuclein in neurodegenerative diseases.
    Bennett MC.
    Pharmacol Ther; 2005 Mar; 105(3):311-31. PubMed ID: 15737408
    [Abstract] [Full Text] [Related]

  • 11. A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human alpha-synuclein A30P + A53T transgenic mice.
    Ono K, Ikemoto M, Kawarabayashi T, Ikeda M, Nishinakagawa T, Hosokawa M, Shoji M, Takahashi M, Nakashima M.
    Parkinsonism Relat Disord; 2009 Nov; 15(9):649-54. PubMed ID: 19345133
    [Abstract] [Full Text] [Related]

  • 12. Threonine 53 in alpha-synuclein is conserved in long-living non-primate animals.
    Larsen K, Hedegaard C, Bertelsen MF, Bendixen C.
    Biochem Biophys Res Commun; 2009 Sep 25; 387(3):602-5. PubMed ID: 19619507
    [Abstract] [Full Text] [Related]

  • 13. Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.
    Kumar S, Sarkar A, Sundar D.
    Biochem Biophys Res Commun; 2009 Sep 18; 387(2):305-9. PubMed ID: 19580781
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathogenic effects of alpha-synuclein aggregation.
    Lundvig D, Lindersson E, Jensen PH.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):3-17. PubMed ID: 15790525
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ, Choi MY, Im H.
    Biochem Biophys Res Commun; 2009 Aug 14; 386(1):165-9. PubMed ID: 19501571
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H, Wu YC, Nakamura M, Liang Y, Tanaka Y, Holmes S, Dawson VL, Dawson TM, Ross CA, Smith WW.
    Neurobiol Aging; 2007 Nov 14; 28(11):1709-17. PubMed ID: 16978743
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.